| Paris | |
| 0 | |
| Protip imagines and develops breakthrough medical devices to treat widespread larynx disease | |
| NewBreez device is addressing patients who suffer from repeated aspirations. Aspirations is a common condition that can follow stroke, neurodegenerative disease or larynx cancer. NewBreez is CE marked and is currently under clinical trial in various European countries. | |
| BERENGER Maurice | |
| www.protipmedical.com | |
| Private Equity |
Fiche créée le 10/04/2016 par 
Guillaume vue 7 fois.